Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000593037 | SCV000702469 | pathogenic | not provided | 2016-10-06 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000700865 | SCV000829640 | pathogenic | Cone-rod dystrophy 6; Leber congenital amaurosis 1 | 2018-04-06 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. Loss-of-function variants in GUCY2D are known to be pathogenic (PMID: 10951519, 11328726, 17964524). This variant has been reported to segregate with Leber congenital amaurosis in a family (PMID: 10636733). This variant is also known as c.2646C>T in the literature. This variant is not present in population databases (ExAC no frequency). This sequence change creates a premature translational stop signal (p.Gln855*) in the GUCY2D gene. It is expected to result in an absent or disrupted protein product. |
Mendelics | RCV000989742 | SCV001140286 | pathogenic | Cone-rod dystrophy 6 | 2019-05-28 | criteria provided, single submitter | clinical testing |